Shanghai - Delayed Quote CNY

Bloomage BioTechnology Corporation Limited (688363.SS)

48.66
-0.34
(-0.69%)
As of 2:27:01 PM GMT+8. Market Open.
Loading Chart for 688363.SS
  • Previous Close 49.00
  • Open 49.00
  • Bid 48.65 x --
  • Ask 48.67 x --
  • Day's Range 48.42 - 49.00
  • 52 Week Range 42.51 - 84.59
  • Volume 1,979,867
  • Avg. Volume 3,243,401
  • Market Cap (intraday) 23.438B
  • Beta (5Y Monthly) 0.84
  • PE Ratio (TTM) 811.00
  • EPS (TTM) 0.06
  • Earnings Date --
  • Forward Dividend & Yield 0.38 (0.78%)
  • Ex-Dividend Date Aug 8, 2024
  • 1y Target Est --

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is headquartered in Jinan, the People's Republic of China.

www.bloomagebioactive.com

4,444

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 688363.SS

View More

Performance Overview: 688363.SS

Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

688363.SS
4.66%
SSE Composite Index (000001.SS)
0.45%

1-Year Return

688363.SS
21.43%
SSE Composite Index (000001.SS)
6.73%

3-Year Return

688363.SS
61.73%
SSE Composite Index (000001.SS)
10.21%

5-Year Return

688363.SS
54.46%
SSE Composite Index (000001.SS)
16.44%

Compare To: 688363.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 688363.SS

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    23.60B

  • Enterprise Value

    23.33B

  • Trailing P/E

    816.67

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.68

  • Price/Book (mrq)

    3.41

  • Enterprise Value/Revenue

    4.59

  • Enterprise Value/EBITDA

    417.23

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.64%

  • Return on Assets (ttm)

    0.44%

  • Return on Equity (ttm)

    0.37%

  • Revenue (ttm)

    5.09B

  • Net Income Avi to Common (ttm)

    32.79M

  • Diluted EPS (ttm)

    0.06

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    680.99M

  • Total Debt/Equity (mrq)

    5.90%

  • Levered Free Cash Flow (ttm)

    -134.78M

Research Analysis: 688363.SS

View More

Company Insights: 688363.SS

Research Reports: 688363.SS

View More

People Also Watch